Improving glycaemic control in children and adolescents: Which aspects of therapy really matter?

Diabetic Medicine

Volumn 27, Issue 4, 2010, Pages 369-375

  Skinner, T C ^a   Cameron, F J ^b  

^a Combined Universities Centre for Rural Health   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Children; Efficacy; HbA1C; Intensive therapy

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; ISOPHANE INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADOLESCENT; CHILD; CHILD PARENT RELATION; COPING BEHAVIOR; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; PATIENT SELECTION; PROGNOSIS; PSYCHOLOGICAL WELL BEING; PSYCHOSOCIAL CARE; REVIEW; SELF CARE; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; FEMALE; MALE; MOTIVATION; PATIENT CARE; PRESCHOOL CHILD; PSYCHOLOGY; SOCIAL SUPPORT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GOALS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PATIENT CARE; SELF CARE; SOCIAL SUPPORT;

EID: 77950633607     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02895.x     Document Type: Review

References (82)

1. Ludvigsson J, Bolli GB. Intensive insulin treatment in diabetic children. Diabetes Nutr Metab 2001 14 : 292 304. (Pubitemid 34026511)
2. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 986. (Pubitemid 23307905)
3. American Diabetes Association. Implications of the diabetes control and complications trial. Diabetes Care 2003 26 : S25 S27.
4. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. J Pediatr 1994 125 : 177 188.
5. Knerr I, Hofer SE, Holterhus PM, Näke A, Rosenbauer J, Weitzel D et al. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria. Diabet Med 2007 24 : 1478 1481. (Pubitemid 350179429)
6. Couper JJ, Jones TW, Donaghue KC, Clarke CF, Thomsett MJ, Silink M. The diabetes control and complications trial. Implications for children and adolescents. Australasian Paediatric Endocrine Group. Med J Aust 1995 162 : 369 372.
7. International Society for Pediatric and Adolescent Diabetes (2006-2008). ISPAD Clinical Practice Consensus Guidelines 2006-2008. Available at http://www.ispad.org/FileCenter.html?CategoryID=5 Last accessed 25 April 2009.
8. National Institute for Health and Clinical Excellence (2006). NICE and Diabetes: A Summary of Relevant Guidelines. Available at http://www.diabetes. nhs.uk/downloads/NICE-and-Diabetes.pdf Last accessed 25 April 2009.
9. Canadian Diabetes Association (2008). Canadian Diabetes Association 2008 Clinical Practice Guidelines. Available at http://www.diabetes.ca/for- professionals/resources/2008-cpg/ Last accessed 25 April 2009.
10. American Diabetes Association (2007). Clinical Practice Recommendations. Available at http://www.diabetes.org/for-health-professionals-and-scientists/ cpr.jsp Last accessed 25 April 2009.
11. National Health and Medical Research Council (2007). Clinical Practice Guidelines: Type 1 Diabetes in Children and Adolescents. Available at http://www.nhmrc.gov.au/publications/synopses/cp102syn.htm Last accessed 25 April 2009.
12. Wysocki T, Harris MA, Wilkinson K, Sadler M, Mauras N, White NH. Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care 2003 26 : 2043 2047. (Pubitemid 41184249)
13. Anderson B. Who benefits from intensive therapy in type 1 diabetes? Diabetes Care 2003 26 : 2204 2206.
14. Gale EA, Beattie SD, Hu J, Koivisto V, Tan MH. Recruitment to a clinical trial improves glycemic control in patients with diabetes. Diabetes Care 2007 30 : 2989 2992. (Pubitemid 350255230)
15. Hathout EH, Fujishige L, Geach J, Ischandar M, Maruo S, Mace JW. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes. Diabetes Technol Ther 2003 5 : 801 806. (Pubitemid 37339542)
16. Colino E, López-Capapé M, Golmayo L, Alvarez MA, Alonso M, Barrio R. Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2005 70 : 1 7. (Pubitemid 41207640)
17. Jackson A, Ternand C, Brunzell C, Kleinschmidt T, Dew D, Milla C et al. Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes. Pediatr Diabetes 2003 4 : 64 69. (Pubitemid 36818097)
18. Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K. Pediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes. Diabetes Care 2001 24 : 2005 2006.
19. Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 2003 143 : 737 740. (Pubitemid 37510641)
20. Tan CY, Wilson DM, Buckingham B. Initiation of insulin glargine in children and adolescents with type 1 diabetes. Pediatr Diabetes 2004 5 : 80 86. (Pubitemid 38923634)
21. Dixon B, Chase HP, Burdick J, Fiallo-Scharer R, Walravens P, Klingensmith G et al. Use of insulin glargine in children under age 6 with type 1 diabetes. Pediatr Diabetes 2005 6 : 150 154. (Pubitemid 41223240)
22. Päivärinta M, Tapanainen P, Veijola R. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes. Pediatr Diabetes 2008 9 : 83 90. (Pubitemid 351784999)
23. Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes. Pediatrics 2008 121 : e466 e472.
24. Chase HP, Arslanian S, White NH, Tamborlane WV. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. J Pediatr 2008 153 : 547 553.
25. Alemzadeh R, Berhe T, Wyatt DT. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 2005 115 : 1320 1324. (Pubitemid 43843238)
26. Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabet Med 2007 24 : 27 34. (Pubitemid 46103068)
27. Nguyen TM, Mason KJ, Sanders CG, Yazdani P, Heptulla RA. Targeting blood glucose management in school improves glycemic control in children with poorly controlled type 1 diabetes mellitus. J Pediatr 2008 153 : 575 578.
28. Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006 19 : CD003287.
29. Cherubini V, Iannilli A, Iafusco D, Cardella F, Giamprini MS, Fanelli C et al. Premeal insulin treatment during basal-bolus regimen in young children with type 1 diabetes. Diabetes Care 2006 29 : 2311 2312.
30. Craig ME, Handelsman P, Donaghue KC, Chan A, Blades B, Laina R et al. Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med J Aust 2002 177 : 235 238.
31. Dorchy H. Improving outcomes for young people with diabetes. Diabet Med 2002 19 : 702 703.
32. Yokota I, Amemiya S, Kida K, Sasaki N, Matsuura N, Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes. Past 10-year status of insulin therapy for preschool-age Japanese children with type 1 diabetes. Diabetes Res Clin Pract 2005 67 : 227 233.
33. de Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 2007 30 : 2245 2250.
34. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997 130 : 257 265.
35. Vanelli M, Chiarelli F, Chiari G, Tumini S, Costi G, di Ricco L et al. Metabolic control in children and adolescents with diabetes: experience of two Italian Regional Centers. J Pediatr Endocrinol Metab 1999 12 : 403 409.
36. Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004 144 : 660 661.
37. Nordly S, Mortensen HB, Andreasen AH, Hermann N, Jørgensen T. Factors associated with glycaemic outcome of childhood diabetes care in Denmark. Diabet Med 2005 22 : 1566 1573.
38. Holl RW, Swift PG, Mortensen HB, Lynggaard H, Hougaard P, Aanstoot HJ et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr 2003 162 : 22 29.
39. Mortensen HB, Villumsen J, Vølund A, Petersen KE, Nerup J. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med 1992 9 : 834 839.
40. Scottish Study Group for the Care of the Young with Diabetes. A longitudinal observational study of insulin therapy and glycaemic control in Scottish children with Type 1 diabetes: DIABAUD 3. Diabet Med 2006 23 : 1216 1221.
41. Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM et al. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med 2008 25 : 80 85.
42. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004 27 : 1554 1558.
43. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005 28 : 1277 1281.
44. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005 28 : 15 19.
45. Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008 51 : 941 951.
46. Pańkowska E, Błazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009 10 : 52 58.
47. McMahon SK, Airey FL, Marangou DA, McElwee KJ, Carne CL, Clarey AJ et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med 2005 22 : 92 96.
48. Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M et al. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr 2006 149 : 227 232.
49. Kapellen TM, Heidtmann B, Bachmann J, Ziegler R, Grabert M, Holl RW. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents. Diabet Med 2007 24 : 836 842.
50. Battelino T. Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents. Pediatr Diabetes 2006 7 (Suppl. 4 20 24.
51. McVean JJ, Eickhoff JC, MacDonald MJ. Factors correlating with improved A1C in children using continuous subcutaneous insulin infusion. Diabetes Care 2007 30 : 2499 2500.
52. Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 2008 51 : 1594 1601.
53. Cope JU, Morrison AE, Samuels-Reid J. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics 2008 121 : e1133 e1138.
54. Evans JMM, Newton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ 1999 319 : 83 86.
55. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997 350 : 1505 1510.
56. Couper JJ, Taylor J, Fotheringham MJ, Sawyer M. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care 1999 22 : 1933 1937.
57. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001 139 : 804 812.
58. Chambless DL, Ollendick TH. Empirically supported psychological interventions: controversies and evidence. Annu Rev Psychol 2001 52 : 685 716.
59. Crow R, Gage H, Hampson S, Hart J, Kimber A, Thomas H. The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess 1999 3 : 1 96.
60. Skinner TC, Hampson SE. Personal models of diabetes in relation to self-care, well-being and glycemic control: a prospective study in adolescence. Diabetes Care 2001 24 : 888 892.
61. Skinner TC, Hampson SE, Fife-Schaw C. Personality, personal model beliefs, and self-care in adolescents and young adults with Type 1 diabetes. Health Psychol 2002 21 : 61 70.
62. McCaul KD, Glasgow RE, Schafer LC. Diabetes regimen behaviour: predicting adherence. Med Care 1987 25 : 868 881.
63. Grossman HY, Brink S, Hauser ST. Self-efficacy in adolescent girls and boys with insulin-dependent diabetes mellitus. Diabetes Care 1987 10 : 324 329.
64. Littlefield CH, Daneman D, Craven JL, Murray MA, Rodin GM, Rydall AC. Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescents. Diabetes Care 1992 15 : 90 94.
65. Schlundt DG, Rea M, Hodge M, Flannery ME, Kline S, Meek J et al. Assessing and overcoming situational obstacles to dietary adherence in adolescents with IDDM. J Adolesc Health 1996 19 : 282 288.
66. Palardy N, Greening L, Ott J, Holderby A, Atchison J. Adolescents' health attitudes and adherence to treatment for insulin-dependent diabetes mellitus. J Dev Behav Pediatr 1998 19 : 31 37.
67. Grey M, Sullivan-Bolyai S, Boland EA, Tamborlane WV, Yu C. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 1998 21 : 909 914.
68. Johnston-Brooks CH, Lewis MA, Garg S. Self-efficacy impacts self-care and HbA1c in young adults with type I diabetes. Psychosom Med 2002 64 : 43 51.
69. Page P, Verstraete DG, Robb JR, Etzwiler DD. Patient recall of self-care recommendations in diabetes. Diabetes Care 1981 49 : 96 98.
70. Parkin T, Skinner TC. Discrepancies between patient and professionals recall and perception of an outpatient consultation. Diabet Med 2003 20 : 909 914.
71. Skinner TC, Barnard K, Cradock S, Parking T. Patient and professional accuracy of recalled treatment decisions in outpatient consultations. Diabet Med 2007 24 : 557 560.
72. Swift P, Skinner T, de Beaufort C, Cameron F, Aman J, Aanstoot HJ et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005. Pediatr Diabetes 2009 (in press).
73. Skinner TC, Murphy H, Huws-Thomas MV. Diabetes in adolescents. In Snoek F, Skinner TC, eds. Psychology in Diabetes Care, 2nd edn.
74. Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H et al. Are family dynamics a universally critical determinant of metabolic diabetes outcomes in adolescents with type 1 diabetes? Diabet Med 2008 25 : 463 469.
75. Anderson BJ, Brackett J, Ho J, Laffel L. An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Diabetes Care 1999 22 : 713 721.
76. Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 2003 142 : 409 416.
77. Murphy H, Wadham C, Rayman G, Skinner TC. Approaches to integrating paediatric diabetes care and structured education: experiences from the Families, Adolescents, and Children's Teamwork Study (FACTS). Diabet Med 2007 24 : 1261 1268.
78. Skinner TC, Petzing J, Johnston C. Peer support and metabolic control in adolescence. J Diab Nurs 1999 3 : 140 144.
79. Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr 2000 137 : 107 113.
80. Howells L, Wilson AC, Skinner TC, Newton R, Morris A, Greene SA. A randomised control trial of the effect of contracted negotiated telephone support on glycaemic control in young people with type 1 diabetes. Diabet Med 2002 19 : 643 648.
81. Jefferson IG, Swift PG, Skinner TC, Hood GK. Diabetes services in the UK: third national survey confirms continuing deficiencies. Arch Dis Child 2003 88 : 53 56.
82. Hambly H, Robling M, Crowne E, Hood K, Gregory JW, DEPICTED Study Team. Communication skills of healthcare professionals in paediatric diabetes services. Diabet Med 2009 26 : 502 509.